Clinical Trial Update: Efficiency of Twice Daily Formoterol Versus Once Daily Tiotropium in Patients With GOLD A/B COPD [NA]

View source ↗

Summary

A clinical trial update comparing the efficacy of twice-daily formoterol to once-daily tiotropium in patients with COPD classified as GOLD A/B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Formoterol (formoterol)
• tiotropium (tiotropium)

Snippet

Sponsor: Huashan Hospital | Conditions: Chronic Obstructive Pulmonary Disease | NA | Status: UNKNOWN